Chemogenomics approaches to rationalizing the mode-of-action of traditional chinese and ayurvedic medicines

Journal of Chemical Information and Modeling

Volumn 53, Issue 3, 2013, Pages 661-673

  Mohd Fauzi, Fazlin ^a,b   Koutsoukas, Alexios ^a   Lowe, Robert ^c   Joshi, Kalpana ^d   Fan, Tai Ping ^a   Glen, Robert C ^a   Bender, Andreas ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITI TEKNOLOGI MARA   (Malaysia)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d SYMBIOSIS INTERNATIONAL DEEMED UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; DRUG INTERACTIONS; GLYCOPROTEINS; MEDICAL APPLICATIONS; MEDICINE; PROTEINS;

ANTICANCER TARGETS; AYURVEDIC MEDICINE; CANCER PATHOGENESIS; EXPERIMENTAL EVIDENCE; GLUCOSE TRANSPORTERS; HYPOGLYCEMIC EFFECT; PROTEIN-TYROSINE PHOSPHATASE; TRADITIONAL CHINESE MEDICINE;

BIRDS;

ANTIDIABETIC AGENT; ANTINEOPLASTIC AGENT; G PROTEIN COUPLED RECEPTOR; GPBAR1 PROTEIN, HUMAN; HERBACEOUS AGENT; MULTIDRUG RESISTANCE PROTEIN; PROTEIN TYROSINE PHOSPHATASE; SLC5A1 PROTEIN, HUMAN; SLC5A2 PROTEIN, HUMAN; SODIUM GLUCOSE COTRANSPORTER 1; SODIUM GLUCOSE COTRANSPORTER 2;

ALGORITHM; ARTICLE; ARTIFICIAL INTELLIGENCE; AYURVEDA; CHEMISTRY; CHINESE MEDICINE; COMPUTER SIMULATION; DRUG EFFECT; GENETIC DATABASE; GENETICS; HUMAN; MEDICINAL PLANT;

ALGORITHMS; ANTINEOPLASTIC AGENTS; ARTIFICIAL INTELLIGENCE; COMPUTER SIMULATION; DATABASES, GENETIC; DRUGS, CHINESE HERBAL; HUMANS; HYPOGLYCEMIC AGENTS; MEDICINE, AYURVEDIC; MEDICINE, CHINESE TRADITIONAL; P-GLYCOPROTEIN; PLANTS, MEDICINAL; PROTEIN TYROSINE PHOSPHATASES; RECEPTORS, G-PROTEIN-COUPLED; SODIUM-GLUCOSE TRANSPORTER 1; SODIUM-GLUCOSE TRANSPORTER 2;

EID: 84875462770     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci3005513     Document Type: Article

References (89)

1. Patwardhan, B.; Warude, D.; Pushpangadan, P.; Bhatt, N. Ayurveda and traditional Chinese medicine: a comparative overview Evidence-Based Complementary Altern. Med. 2005, 2, 465-473
2. Miller, L. H.; Su, X. Artemisinin: Discovery from the Chinese Herbal Garden Cell 2011, 146 (6) 855-858
3. Vakil, R. J. A clinical trial of Rauwolfia serpentina in essential hypertension Br. Heart J. 1949, 11, 350-355
4. Dondorp, A. M.; Fanello, C. I.; Hendriksen, I. C. E.; Gomes, E.; Seni, A.; Chhaganlal, K. D.; Bojang, K.; Olaosebikan, R.; Anunobi, N.; Maitland, K.; Kivaya, E.; Agbenyega, T.; Nguah, S. B.; Evans, J.; Gesase, S.; Kahabuka, C.; Mtove, G.; Nadjm, B.; Deen, J.; Mwanga-Amumpaire, J.; Nansumba, M.; Karema, C.; Umulisa, N.; Uwimana, A.; Mokuolu, O. A.; Adedoyin, O. T.; Johnson, W. B. R.; Tshefu, A. K.; Onyamboko, M. A.; Sakulthaew, T.; Ngum, W. P.; Silamut, K.; Stepniewska, K.; Woodrow, C. J.; Bethell, D.; Wills, B.; Oneko, M.; Peto, T. E.; von Seidlein, L.; Day, N. P. J.; White, N. J. Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial Lancet 2010, 376 (9753) 1647-1657
5. Zhou, L.; Zuo, Z.; Chow, M. S. S. Danshen: An overview of its chemistry, pharmacology, pharmacokinetics, and clinical use J. Clin. Pharmacol. 2005, 45 (12) 1345-1359
6. Xutian, S.; Zhang, J.; Louise, W. New exploration and understanding of traditional Chinese medicine Am. J. Chin. Med. 2009, 37, 411-426
7. Jayasundar, R. Ayurveda: a distinctive approach to health and disease Curr. Sci. 2010, 98, 908-914
8. Patwardhan, B.; Mashelkar, R. A. Traditional medicine-inspired approached to drug discovery: can Ayurveda show the way forward Drug Discovery Today 2009, 14 (15-16) 804-811
9. Arrowsmith, J. Trial watch: Phase II failures: 2008-2010 Nat. Rev. Drug Discovery 2011, 10 (5) 328-329
10. Schmidt, B. M.; Ribnicky, D. M.; Lipsky, P. E.; Raskin, I. Revisiting the ancient concept of botanical therapeutics Nat. Chem. Biol. 2007, 3 (7) 360-366
11. Li, J. W.-H.; Vederas, J. C. Drug discovery and natural products: End of an era or an endless frontier? Science 2009, 325 (5937) 161-165
12. Ganesan, A. The impact of natural products upon modern drug discovery Curr. Opin. Chem. Biol. 2008, 12, 306-317
13. Evans, B. E.; Rittle, K. E.; Bock, M. G.; DiPardo, R. M.; Freidinger, R. M.; Whitter, W. L.; Lundell, G. F.; Veber, D. F.; Anderson, P. S. Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists J. Med. Chem. 1988, 31 (12) 2235-2246
14. Breinbauer, R.; Vetter, I. R.; Waldmann, H. From protein domains to drug candidates-natural products as guiding principles in the design and synthesis of compound libraries Angew. Chem., Int. Ed. 2002, 41 (16) 2878-2890
15. Kruger, F. A.; Overington, J. P. Global analysis of small molecule binding to related protein targets PLoS Comput. Biol. 2012, 8 (1) e1002333
16. Corson, T. W.; Crews, C. M. Molecular understanding and modern application of traditional medicines: Triumphs and trials Cell 2007, 130 (5) 769-774
17. Chen, C. Y.-C. TCM Database@Taiwan: the world's largest traditional Chinese medicine database for drug screening in silico PLoS One 2011, 6, e15939
18. Vetrivel, U.; Subramanian, N.; Pilla, K.; Campus, R. Bioinformation InPACdb-Indian plant anticancer compounds database bioinformation Cancer 2009, 2063, 71-74
19. Swinney, D. C.; Anthony, J. How were new medicines discovered? Nat. Rev. Drug Discovery 2011, 10, 507-519
20. Koutsoukas, A.; Simms, B.; Kirchmair, J.; Bond, P. J.; Whitmore, A. V.; Zimmer, S.; Young, M. P.; Jenkins, J. L.; Glick, M.; Glen, R. C.; Bender, A. From in silico target prediction to multi-target drug design: Current databases, methods and applications J. Proteomics 2011, 10.1016/j.jprot.2011.05.011
21. Young, D. W.; Bender, A.; Hoyt, J.; McWhinnie, E.; Chirn, G.-W.; Tao, C. Y.; Tallarico, J. A.; Labow, M.; Jenkins, J. L.; Mitchison, T. J.; Feng, Y. Integrating high-content screening and ligand-target prediction to identify mechanism of action Nat. Chem. Biol. 2008, 4, 59-68
22. Scheiber, J.; Chen, B.; Milik, M.; Sukuru, S. C. K.; Bender, A.; Mikhailov, D.; Whitebread, S.; Hamon, J.; Azzaoui, K.; Urban, L.; Glick, M.; Davies, J. W.; Jenkins, J. L. Gaining insight into off-target mediated effects of drug candidates with a comprehensive systems chemical biology analysis J. Chem. Inf. Model. 2009, 49 (2) 308-317
23. Zhang, S.; Lu, W.; Liu, X.; Diao, Y.; Bai, F.; Wang, L.; Shan, L.; Huang, J.; Li, H.; Zhang, W. Fast and effective identification of the bioactive compounds and their targets from medicinal plants via computational chemical biology approach MedChemComm 2011, 2 (6) 471-477
24. Ehrman, T. M.; Barlow, D. J.; Hylands, P. J. In silico search for multi-target anti-inflammatories in Chinese herbs and formulas Bioorg. Med. Chem. 2010, 18, 2204-2218
25. Ehrman, T.; Barlow, D.; Hylands, P. Phytochemical informatics of traditional Chinese medicine and therapeutic relevance J. Chem. Inf. Model. 2007, 47, 2316-2334
26. Gaulton, A.; Bellis, L. J.; Bento, A. P.; Chambers, J.; Davies, M.; Hersey, A.; Light, Y.; McGlinchey, S.; Michalovich, D.; Al-Lazikani, B.; Overington, J. P. ChEMBL: a large-scale bioactivity database for drug discovery Nucleic Acids Res. 2012, 40 (D1) D1100-D1107
27. Rogers, D.; Hahn, M. Extended-connectivity fingerprints J. Chem. Inf. Model. 2010, 50 (5) 742-754
28. Flach, P. A.; Lachiche, N. Naive Bayesian classification of structured data Machine Learning 2004, 57, 233-269
29. Ko, K. M.; Leung, H. Y. Enhancement of ATP generation capacity, antioxidant activity and immunomodulatory activities by Chinese yang and yin tonifying herbs Chin. Med. 2007, 2, 3
30. Kim, K.-M.; Kwon, Y.-G.; Chung, H.-T.; Yun, Y.-G.; Pae, H.-O.; Han, J.-A.; Ha, K.-S.; Kim, T.-W.; Kim, Y.-M. Methanol extract of Cordyceps pruinosa inhibits in vitro and in vivo inflammatory mediators by suppressing NF-κB activation Toxicol. Appl. Pharmacol. 2003, 190 (1) 1-8
31. Zhao, C.-S.; Yin, W.-T.; Wang, J.-Y.; Zhang, Y.; Yu, H.; Cooper, R.; Smidt, C.; Zhu, J.-S. CordyMax Cs-4 improves glucose metabolism and increases insulin sensitivity in normal rats J. Altern. Complementary Med. 2005, 8 (3) 309-314
32. Chen, Y.-J.; Shiao, M.-S.; Lee, S.-S.; Wang, S.-Y. Effect of Cordyceps sinensis on the proliferation and differentiation of human leukemic U937 cells Life Sci. 1997, 60 (25) 2349-2359
33. Chiou, W.-F.; Chang, P.-C.; Chou, C.-J.; Chen, C.-F. Protein constituent contributes to the hypotensive and vasorelaxant acttvtties of cordyceps sinensis Life Sci. 2000, 66 (14) 1369-1376
34. Idris, I.; Donnelly, R. Sodium-glucose co-transporter-2 inhibitors: an emerging new class of oral antidiabetic drug Diabetes, Obes. Metab. 2009, 11 (2) 79-88
35. Stuible, M.; Doody, K.; Tremblay, M. PTP1B and TC-PTP: regulators of transformation and tumorigenesis Cancer Metastasis Rev. 2008, 27 (2) 215-230
36. Dubois, R. N.; Abramson, S. B.; Crofford, L.; Gupta, R. A.; Simon, L. S.; A. Van De Putte, L. B.; Lipsky, P. E. Cyclooxygenase in biology and disease FASEB J. 1998, 12 (12) 1063-1073
37. Blann, A. D.; Nadar, S. K.; Lip, G. Y. H. The adhesion molecule P-selectin and cardiovascular disease Eur. Heart J. 2003, 24 (24) 2166-2179
38. Dumic, J.; Dabelic, S.; Flögel, M. Galectin-3: An open-ended story Biochim. Biophys. Acta, Gen. Subj. 2006, 1760 (4) 616-635
39. Danguy, A.; Camby, I.; Kiss, R. Galectins and cancer Biochim. Biophys. Acta, Gen. Subj. 2002, 1572 (2-3) 285-293
40. Ferrari, P. The role of 11β-hydroxysteroid dehydrogenase type 2 in human hypertension Biochim. Biophys. Acta, Mol. Basis Dis. 2010, 1802 (12) 1178-1187
41. Ernst, M. E.; Fravel, M. A. Febuxostat: A selective xanthine-oxidase/ xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout Clin. Ther. 2009, 31 (11) 2503-2518
42. Burnstock, G. Purine and pyrimidine receptors Cell. Mol. Life Sci. 2007, 64 (12) 1471-1483
43. Jin, D.-Q.; Park, B.-C.; Lee, J.-S.; Choi, H.-D.; Lee, Y.-S.; Yang, J.-H.; Kim, J.-A. Mycelial extract of Cordyceps ophioglossoides prevents neuronal cell death and ameliorates b-amyloid peptide-induced memory deficits in rats Biol. Pharm. Bull. 2004, 27 (7) 1126-1129
44. Novak, K. Conference Report-Protein Kinase Inhibitors in Cancer Treatment: Mixing and Matching? In Proceedings of the Keystone Symposium on Protein Kinases and Cancer, Medscape General Medicine: Lake Tahoe, CA, USA, 2004.
45. Kawamata, Y.; Fujii, R.; Hosoya, M.; Harada, M.; Yoshida, H.; Miwa, M.; Fukusumi, S.; Habata, Y.; Itoh, T.; Shintani, Y.; Hinuma, S.; Fujisawa, Y.; Fujino, M. A G protein-coupled receptor responsive to bile acids J. Biol. Chem. 2003, 278 (11) 9435-9440
46. Watanabe, M.; Houten, S. M.; Mataki, C.; Christoffolete, M. A.; Kim, B. W.; Sato, H.; Messaddeq, N.; Harney, J. W.; Ezaki, O.; Kodama, T.; Schoonjans, K.; Bianco, A. C.; Auwerx, J. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation Nature 2006, 439 (7075) 484-489
47. Barnett, D. H.; Sheng, S.; Howe Charn, T.; Waheed, A.; Sly, W. S.; Lin, C.-Y.; Liu, E. T.; Katzenellenbogen, B. S. Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer Cancer Res. 2008, 68 (9) 3505-3515
48. Türeci, Ö.; Sahin, U.; Vollmar, E.; Siemer, S.; Göttert, E.; Seitz, G.; Parkkila, A.-K.; Shah, G. N.; Grubb, J. H.; Pfreundschuh, M.; Sly, W. S. Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers Proc. Natl. Acad. Sci. 1998, 95 (13) 7608-7613
49. Park, H. S.; Chun, J. N.; Jung, H. Y.; Choi, C.; Bae, Y. S. Role of NADPH oxidase 4 in lipopolysaccharide-induced proinflammatory responses by human aortic endothelial cells Cardiovasc. Res. 2006, 72 (3) 447-455
50. Kuroda, J.; Ago, T.; Matsushima, S.; Zhai, P.; Schneider, M. D.; Sadoshima, J. NADPH oxidase 4 (Nox4) is a major source of oxidative stress in the failing heart Proc. Natl. Acad. Sci. 2010, 107 (35) 15565-15570
51. Ko, K.-M.; Mak, D. H. F.; Chiu, P.-Y.; Poon, M. K. T. Pharmacological basis of 'yang-invigoration' in Chinese medicine Trends Pharmacol. Sci. 2004, 25 (1) 3-6
52. O'Donnell, A.; Judson, I.; Dowsett, M.; Raynaud, F.; Dearnaley, D.; Mason, M.; Harland, S.; Robbins, A.; Halbert, G.; Nutley, B.; Jarman, M. Hormonal impact of the 17[alpha]-hydroxylase//C17,20-lyase inhibitor abiraterone acetate (CB7630) in patients with prostate cancer Br. J. Cancer 2004, 90 (12) 2317-2325
53. Hsu, C.-C.; Tsai, S.-J.; Huang, Y.-L.; Huang, B.-M. Regulatory mechanism of Cordyceps sinensis mycelium on mouse Leydig cell steroidogenesis FEBS Lett. 2003, 543 (1) 140-143
54. Elchebly, M.; Payette, P.; Michaliszyn, E.; Cromlish, W.; Collins, S.; Loy, A. L.; Normandin, D.; Cheng, A.; Himms-Hagen, J.; Chan, C.-C.; Ramachandran, C.; Gresser, M. J.; Tremblay, M. L.; Kennedy, B. P. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene Science 1999, 283 (5407) 1544-1548
55. Xie, J.-t.; Wang, C.-z.; Wang, A.-b.; Wu, J.; Basila, D.; Yuan, C.-s. Antihyperglycemic effects of total ginsenosides from leaves and stem of Panax ginseng Acta Pharmacol. Sin. 2005, 26 (9) 1104-1110
56. Dou, D.-Q.; Zhang, Y.-W.; Zhang, L.; Chen, Y.-J.; Yao, X.-S. The inhibitory effects of ginsenosides on protein tyrosine kinase activated by hypoxia/reoxygenation in cultured human umbilical vein endothelial cells Planta Med. 2001, 67 (1) 19-23
57. Surh, Y.-J.; Lee, J.-Y.; Choi, K.-J.; Ko, S.-R. Effects of selected ginsenosides on phorbol ester-induced expression of cyclooxygenase-2 and activation of NF-κB and ERK1/2 in mouse skin Ann. N.Y. Acad. Sci. 2002, 973 (1) 396-401
58. Roderick, H. L.; Cook, S. J. Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival Nat. Rev. Cancer 2008, 8 (5) 361-375
59. Thomas, L. N.; Douglas, R. C.; Lazier, C. B.; Too, C. K. L.; Rittmaster, R. S.; Tindall, D. J. Type 1 and type 2 5α-reductase expression in the development and progression of prostate cancer Eur. Urol. 2008, 53 (2) 244-252
60. Richer, J. K.; Jacobsen, B. M.; Manning, N. G.; Abel, M. G.; Wolf, D. M.; Horwitz, K. B. Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells J. Biol. Chem. 2002, 277 (7) 5209-5218
61. Patel, K. J.; Tannock, I. F. The influence of P-glycoprotein expression and its inhibitors on the distribution of doxorubicin in breast tumors. BMC Cancer 2009, 9, (356), doi: 10.1186/1471-2407-1189-1356.
62. Martel, C.; Rhéaume, E.; Takahashi, M.; Trudel, C.; Couët, J.; Luu-The, V.; Simard, J.; Labrie, F. Distribution of 17 beta-hydroxysteroid dehydrogenase gene expression and activity in rat and human tissues J. Steroid Biochem. Mol. Biol. 1992, 41, 563-603
63. Julien, S. G.; Dube, N.; Read, M.; Penney, J.; Paquet, M.; Han, Y.; Kennedy, B. P.; Muller, W. J.; Tremblay, M. L. Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis Nat. Genet. 2007, 39 (3) 338-346
64. Doody, K. M.; Bourdeau, A.; Tremblay, M. L. T-cell protein tyrosine phosphatase is a key regulator in immune cell signaling: lessons from the knockout mouse model and implications in human disease Immunol. Rev. 2009, 228 (1) 325-341
65. Lin, T. S.; Mahajan, S.; Frank, D. A. STAT signaling in the pathogenesis and treatment of leukemias Oncogene 2000, 19 (21) 2496-2504
66. Khwaja, A. The role of Janus kinases in haemopoiesis and haematological malignancy Br. J. Hamaetol. 2006, 134 (4) 366-384
67. Stermitz, F. R.; Lorenz, P.; Tawara, J. N.; Zenewicz, L. A.; Lewis, K. Synergy in a medicinal plant: Antimicrobial action of berberine potentiated by 5′-methoxyhydnocarpin, a multidrug pump inhibitor Proc. Natl. Acad. Sci. U. S. A. 2000, 97 (4) 1433-1437
68. Wang, L.; Zhou, G.-B.; Liu, P.; Song, J.-H.; Liang, Y.; Yan, X.-J.; Xu, F.; Wang, B.-S.; Mao, J.-H.; Shen, Z.-X.; Chen, S.-J.; Chen, Z. Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia Proc. Natl. Acad. Sci. U. S. A. 2008, 105 (12) 4826-4831
69. 2+ release is inhibited by boric acid in prostate cancer cells. PLoS One 2009, 4, (6), doi: 10.1371/journal.pone.0006009.
70. Mariot, P.; Prevarskaya, N.; Roudbaraki, M. M.; Le Bourhis, X.; Van Coppenolle, F.; Vanoverberghe, K.; Skryma, R. Evidence of functional ryanodine receptor involved in apoptosis of prostate cancer (LNCaP) cells Prostate 2000, 43 (3) 205-214
71. Flourakis, M.; Prevarskaya, N. Insights into Ca2+ homeostasis of advanced prostate cancer cells Biochim. Biophys. Acta, Mol. Cell Res. 2009, 1793 (6) 1105-1109
72. Abdul, M.; Ramlal, S.; Hoosein, N. Ryanodine receptor expression correlates with tumor grade in breast cancer Pathol. Oncol. Res. 2008, 14 (2) 157-160
73. Shamash, J.; Salam, A. H.; Davies, D. C.; Williams, A.; Joel, S.; Lister, T. A. In vitro testing of calcium channel blockers and cytotoxic chemotherapy in B-cell low-grade non-Hodgkin's lymphoma Br. J. Cancer 1998, 77 (10) 1598-1603
74. Kim, B.-C.; Kim, H.-T.; Mamura, M.; Ambudkar, I. S.; Choi, K.-S.; Kim, S.-J. Tumor necrosis factor induces apoptosis in hepatoma cells by increasing Ca2+ release from the endoplasmic reticulum and suppressing Bcl-2 expression J. Biol. Chem. 2002, 277 (35) 31381-31389
75. Yasuda, H.; Hirata, S.; Inoue, K.; Mashima, H.; Ohnishi, H.; Yoshiba, M. Involvement of membrane-type bile acid receptor M-BAR/TGR5 in bile acid-induced activation of epidermal growth factor receptor and mitogen-activated protein kinases in gastric carcinoma cells Biochem. Biophys. Res. Commun. 2007, 354 (1) 154-159
76. Hong, J.; Behar, J.; Wands, J.; Resnick, M.; Wang, L. J.; DeLellis, R. A.; Lambeth, D.; Souza, R. F.; Spechler, S. J.; Cao, W. Role of a novel bile acid receptor TGR5 in the development of oesophageal adenocarcinoma Gut 2010, 59 (2) 170-180
77. Brunton, L. L.; Blumenthal, D. K.; Buxton, I. L. O.; Parker, K. L. Goodman & Gilman's Manual of Pharmacology and Therapeutics; McGraw-Hill: United State of America, 2008.
78. Pommier, Y.; Leo, E.; Zhang, H.; Marchand, C. DNA topoisomerases and their poisoning by anticancer and antibacterial drugs Chem. Biol. 2010, 17 (5) 421-433
79. Wall, M. E.; Wani, M. C.; Cook, C. E.; Palmer, K. H.; McPhail, A. T.; Sim, G. A. Plant antitumor agents. I. The isolation and structure of camptothecin, a novel alkaloidal leukemia and tumor inhibitor from Camptotheca acuminata J. Am. Chem. Soc. 1966, 88 (16) 3888-3890
80. Jarvinen, T., A. H.; Pelto-Huikko, M.; Holli, K.; Isola, J. Estrogen receptor b is coexpressed with ERa and PR and associated with nodal status, grade and proliferation rate in breast cancer Am. J. Pathol. 2000, 156 (1) 29-35
81. Garland, S. L.; Gloriam, D. E. A ligand's view of target similarity: Chemogenomic binding-site directed techniques for drug discovery Curr. Top. Med. Chem. 2011, 11, 1872-1881
82. Sheu, J.-H.; Wang, G.-H.; Sung, P.-J.; Duh, C.-Y. New cytotoxic oxygenated fucosterols from the brown Alga Turbinaria conoides J. Nat. Prod. 1998, 62 (2) 224-227
83. Wani, M. C.; Nicholas, A. W.; Wall, M. E. Plant antitumor agents. 23. Synthesis and antileukemic activity of camptothecin analogs J. Med. Chem. 1986, 29 (11) 2358-2363
84. Koutsoukas, A.; Lowe, R.; Kalantar-Motamedi, Y.; Mussa, H. Y.; Mitchell, J. B. O.; Glen, R. C.; Bender, A. In silico target predictions: comparing multiclass Naïve Bayes and Parzen-Rosenblatt Window and the definition of a benchmarking dataset for target prediction. J. Chem. Inf. Model. 2013, Submitted.
85. Morgan, H. L. The generation of a unique machine description for chemical structures J. Chem. Doc. 1965, 5, 107-113
86. Gasteiger, J.; Engel, T. Chemoinformatics: A Textbook; Wiley-VCH: Weinheim, 2003.
87. Kirchmair, J.; Markt, P.; Distinto, S.; Wolber, G.; Langer, T. Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection - what can we learn from earlier mistakes? J. Comput.-Aided Mol. Des. 2008, 22, 213-228
88. Bolton, E.; Wang, Y.; Thiessen, P. A.; Bryant, S. H. PubChem: Integrated Platform for Small Molecules and Biological Activities. In Annual Reports in Computational Chemistry; American Chemical Society: Washington, DC, 2008; Vol. 4.
89. Blum, L. C.; Reymond, J.-L. 970 million druglike small molecules for virtual screening in the chemical universe database GDB-13 J. Am. Chem. Soc. 2009, 131 (25) 8732-8733